State of the heart: Building science to improve women's cardiovascular health

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Cardiovascular disease is the No. 1 killer of women in the United States, and marked disparities in cardiovascular health exist between women and men and among groups of women. Coronary heart disease is underdiagnosed, undertreated, and underresearched in women. Women with suspected heart disease are less likely than men to receive indicated diagnostic tests and procedures; sex-based biases in treatment of myocardial infarction persist; and women continue to be underrepresented in cardiovascular research. An accumulating body of literature points to 3 major explanations: sex-based physiology, provider bias, and psychosocial influences. Women's acute and prodromal signs and symptoms of myocardial infarction have been described, yet women have difficulty recognizing and acting on these indications. Primary and secondary prevention of heart disease in women is imperative; although the science is lacking in several areas, existing evidence on diet, hormone therapy, aspirin, physical activity and obesity, and diabetes can serve as the basis for interventions. Potentially, large impacts could be made on women's morbidity and mortality if current scientific knowledge were implemented. The state of the science of women and heart disease is reviewed, with a focus on those areas with the greatest potential to address the needs of women's cardiovascular status. Key gaps in the science and remaining questions are presented as a research agenda for the coming decade.

Original languageEnglish (US)
Pages (from-to)556-566
Number of pages11
JournalAmerican Journal of Critical Care
Volume15
Issue number6
StatePublished - 2006
Externally publishedYes

Fingerprint

Women's Health
Prodromal Symptoms
Heart Diseases
Myocardial Infarction
Diet Therapy
Sexism
Women's Rights
Primary Prevention
Secondary Prevention
Research
Routine Diagnostic Tests
Aspirin
Signs and Symptoms
Coronary Disease
Cardiovascular Diseases
Obesity
Hormones
Exercise
Morbidity

ASJC Scopus subject areas

  • Critical Care
  • Medicine(all)
  • Nursing(all)

Cite this

State of the heart : Building science to improve women's cardiovascular health. / Rosenfeld, Anne G.

In: American Journal of Critical Care, Vol. 15, No. 6, 2006, p. 556-566.

Research output: Contribution to journalArticle

@article{81a139dac81741fcb9e369f5e46c3bde,
title = "State of the heart: Building science to improve women's cardiovascular health",
abstract = "Cardiovascular disease is the No. 1 killer of women in the United States, and marked disparities in cardiovascular health exist between women and men and among groups of women. Coronary heart disease is underdiagnosed, undertreated, and underresearched in women. Women with suspected heart disease are less likely than men to receive indicated diagnostic tests and procedures; sex-based biases in treatment of myocardial infarction persist; and women continue to be underrepresented in cardiovascular research. An accumulating body of literature points to 3 major explanations: sex-based physiology, provider bias, and psychosocial influences. Women's acute and prodromal signs and symptoms of myocardial infarction have been described, yet women have difficulty recognizing and acting on these indications. Primary and secondary prevention of heart disease in women is imperative; although the science is lacking in several areas, existing evidence on diet, hormone therapy, aspirin, physical activity and obesity, and diabetes can serve as the basis for interventions. Potentially, large impacts could be made on women's morbidity and mortality if current scientific knowledge were implemented. The state of the science of women and heart disease is reviewed, with a focus on those areas with the greatest potential to address the needs of women's cardiovascular status. Key gaps in the science and remaining questions are presented as a research agenda for the coming decade.",
author = "Rosenfeld, {Anne G}",
year = "2006",
language = "English (US)",
volume = "15",
pages = "556--566",
journal = "American Journal of Critical Care",
issn = "1062-3264",
publisher = "American Association of Critical Care Nurses",
number = "6",

}

TY - JOUR

T1 - State of the heart

T2 - Building science to improve women's cardiovascular health

AU - Rosenfeld, Anne G

PY - 2006

Y1 - 2006

N2 - Cardiovascular disease is the No. 1 killer of women in the United States, and marked disparities in cardiovascular health exist between women and men and among groups of women. Coronary heart disease is underdiagnosed, undertreated, and underresearched in women. Women with suspected heart disease are less likely than men to receive indicated diagnostic tests and procedures; sex-based biases in treatment of myocardial infarction persist; and women continue to be underrepresented in cardiovascular research. An accumulating body of literature points to 3 major explanations: sex-based physiology, provider bias, and psychosocial influences. Women's acute and prodromal signs and symptoms of myocardial infarction have been described, yet women have difficulty recognizing and acting on these indications. Primary and secondary prevention of heart disease in women is imperative; although the science is lacking in several areas, existing evidence on diet, hormone therapy, aspirin, physical activity and obesity, and diabetes can serve as the basis for interventions. Potentially, large impacts could be made on women's morbidity and mortality if current scientific knowledge were implemented. The state of the science of women and heart disease is reviewed, with a focus on those areas with the greatest potential to address the needs of women's cardiovascular status. Key gaps in the science and remaining questions are presented as a research agenda for the coming decade.

AB - Cardiovascular disease is the No. 1 killer of women in the United States, and marked disparities in cardiovascular health exist between women and men and among groups of women. Coronary heart disease is underdiagnosed, undertreated, and underresearched in women. Women with suspected heart disease are less likely than men to receive indicated diagnostic tests and procedures; sex-based biases in treatment of myocardial infarction persist; and women continue to be underrepresented in cardiovascular research. An accumulating body of literature points to 3 major explanations: sex-based physiology, provider bias, and psychosocial influences. Women's acute and prodromal signs and symptoms of myocardial infarction have been described, yet women have difficulty recognizing and acting on these indications. Primary and secondary prevention of heart disease in women is imperative; although the science is lacking in several areas, existing evidence on diet, hormone therapy, aspirin, physical activity and obesity, and diabetes can serve as the basis for interventions. Potentially, large impacts could be made on women's morbidity and mortality if current scientific knowledge were implemented. The state of the science of women and heart disease is reviewed, with a focus on those areas with the greatest potential to address the needs of women's cardiovascular status. Key gaps in the science and remaining questions are presented as a research agenda for the coming decade.

UR - http://www.scopus.com/inward/record.url?scp=37249055859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249055859&partnerID=8YFLogxK

M3 - Article

C2 - 17053263

AN - SCOPUS:37249055859

VL - 15

SP - 556

EP - 566

JO - American Journal of Critical Care

JF - American Journal of Critical Care

SN - 1062-3264

IS - 6

ER -